TheraRadar
← Back
Data updated: Mar 29, 2026

RK PHARMA

ImmunologyNeurologyOncology
Generics

RK PHARMA is a generic drug manufacturer focused on Immunology, Neurology, Oncology.

1999
Since
19
Drugs
-
Trials
131
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SELENIOUS ACID 2026-02-03
CLOMIPRAMINE HYDROCHLORIDE 2026-01-28
Labeling
CUPRIC CHLORIDE 2026-01-26
PALIPERIDONE 2026-01-26
MYCOPHENOLATE SODIUM 2026-01-14
Labeling
CARBAMAZEPINE 2026-01-05
Labeling
SELENIOUS ACID 2025-12-31
URSODIOL 2025-11-21
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 28%
1 drugs Phase 3: 3
Neurology 19%
1 drugs Phase 3: 1 Phase 2: 1
Oncology 19%
2 drugs
Dermatology 19%
0 drugs Phase 3: 3
Cardiovascular 16%
1 drugs Phase 3: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Eli Lilly big-pharma
Oncology, Immunology, Neurology, Dermatology
Pfizer big-pharma
Oncology, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Immunology, Oncology
Novartis big-pharma
Oncology, Cardiovascular, Immunology
ADVANZ PHARMA big-pharma
Oncology, Immunology, Neurology, Cardiovascular, Dermatology